LYO-X is providing Quantitative Systems Pharmacology (QSP) and PK/PD modelling services for biotech companies. LYO-X is one of the few providers worldwide in this area and has been supporting over 200 companies globally in translating their highly innovative therapeutic molecules into patients.
Products, services, technology
We support PK/PD and GLP tox study design and analysis, animal-to-human translation, first in human dose selection (MABEL), early clinical dose estimation, dose-regimen finding, bridging to special populations, in particular to pediatrics, for bio-therapeutics and novel formats.
- http://www.lyo-x.com
- +41 79 766 52 70
- Send an email
- Matthias Machacek
Some insights
Our company helps innovators to achieve their dream of bringing a new innovation as a medical treatment to patients.
With a team of 15 people we have been able to make ourselves a global name in the biotechnology field as to-go experts on how to bring new compounds into clinical trials.
The core strength of are dedication, expertise and scientific integrity.
Give us the exposure to showcase our excellence.
